Rho-kinase inhibitors: Role in corneal endothelial disorders.

Seminars in Ophthalmology（2023）

引用 0|浏览0

暂无评分

摘要

Rho-kinase inhibitors show immense promise in providing a non-surgical therapy for treatment of endothelial disorders. If consistent results are demonstrated through large clinical trials then this can be a major breakthrough in treating endothelial decompensation and reduce our dependence on endothelial keratoplasty for the same.

查看译文

关键词

Corneal Endothelium,Endothelial regeneration,Fuchs Endothelial Corneal dystrophy,Rho-kinase inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要